Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2019

Aug 21, 2019

30071_dirs_2019-08-21_f3c3fff9-5041-47c6-b12d-ddee7d5b5d5b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-08-20

Reporting Person: TAYLOR RONALD R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-08-20 ResMed Common Stock S 4429 $136.343 Disposed 19855 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $136.32 to $136.43. The price reported above reflects the weighted average sale price.